ALMIRALL S.A. | 11.6300 / -0.94% |
Date/Time | 01/15 / 17:35 |
Chg. / Chg.(%) | -0.1100 / -0.94% |
Bid | 11.4600 / 300 |
Ask | 11.7300 / 150 |
Open | 11.7400 |
Previous Close | 11.7400 |
High | 11.7400 |
Low | 11.4800 |
Volume [EUR] | 4,017,068.5200 |
Volume [Units] | 357,052 |
Price fixings | 1409 |
ISIN | ES0157097017 |
Security | ALM |
Exchange | Madrid |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 11.470 | ![]() |
|
Madrid | 11.6300 | ![]() |
357,052 |
Cboe Europe .. | 11.60 | ![]() |
47,049 |
Turquoise | 11.61 | ![]() |
21,739 |
London Inter.. | 11.55 | ![]() |
12,392 |
TradeGate | 11.57 | ![]() |
40 |
Frankfurt | 11.7000 | ![]() |
0 |
Berlin | 11.700 | ![]() |
0 |
Stuttgart | 11.500 | ![]() |
0 |
Cboe Europe .. | 11.76 | 1,759 | |
Cboe Europe .. | 11.14 | 877 | |
Nasdaq Other.. | 12.4000 | 1,087 |
News
- Paratek Pharmaceuticals to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference
01/06/2021 / 14:00 - GlobeNewswire - Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group
01/04/2021 / 23:00 - GlobeNewswire - Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
12/15/2020 / 13:00 - GlobeNewswire - Pulmonx Welcomes Two New Members to Its Board of Directors, Adding Expertise in Consumer Marketing and Medical Device Company Growth
12/08/2020 / 14:13 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
12/01/2020 / 22:05 - GlobeNewswire